🔴 Kyverna Therapeutics is trading 5% down today as oil and Treasury yields renew inflation concerns

Kyverna Therapeutics is trading 5.13% down now at $7.12, with the decline best attributed to global risk-off sentiment after broader market weakness emerged on September 23, 2026.

• The Nasdaq Composite is down 1.00% and the S&P 500 0.55%; oil and Treasury yields renewed inflation concerns.
• No fresh company-specific announcement was identified, and biotech-sector context is mixed.